Balance Sheet Data

ADMA Biologics, Inc. (ADMA)

$3.735

+0.01 (+0.13%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 22.7526.7555.9251.0986.52256.68448.37783.211,368.112,389.81
Total Cash (%)
Account Receivables 1.393.4713.2428.5815.5152.0890.97158.90277.56484.85
Account Receivables (%)
Inventories 18.6253.0681.54124.72163.28400.27699.191,221.342,133.433,726.67
Inventories (%)
Accounts Payable 5.909.1711.0712.4313.2362.53109.23190.81333.30582.21
Accounts Payable (%)
Capital Expenditure -2.10-3.81-12.73-13.51-13.91-43.70-76.34-133.35-232.94-406.91
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.